DATAPHARM A/S: Financial statements 2025
CVR: 72323211
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity amounted to DKK 11,750,274. The solvency ratio was 89.9%.
- Profit/Loss
- 657,407 kr.
- Equity
- 11,750,274 kr.
- Total Assets
- 13,065,669 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 657 t. | 11.8 mio. | 0 |
| 2024 | - | - | 651 t. | 11.1 mio. | 0 |
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
Find more companies like DATAPHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of September 18, 2025, Mia Bendix Andersen has joined the board of directors of DATAPHARM A/S.
As of September 17, 2025, Jakob Bjørnholt Tjelum has left the board of directors of DATAPHARM A/S.
DATAPHARM A/S has published its annual report for 2024. The net result was DKK 650,613.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity amounted to DKK 11,750,274.
